Avoidance-driven Decision Making and Learning in Anorexia Nervosa and Bulimia Nervosa
1 other identifier
observational
78
1 country
1
Brief Summary
The purpose of this study is to investigate areas of the brain responsible for avoidance learning in adults with eating disorders using brain imaging techniques, computer tasks, and self-report questionnaires and interviews. The investigators will study changes in brain activity using a procedure called functional magnetic resonance imaging (fMRI). This study will include 78 women with an eating disorder (26 with anorexia nervosa \[AN\], 26 with bulimia nervosa \[BN\]) and 26 healthy controls (HC) aged 18-39. Aim 1: Evaluate behavioral differences in active and passive avoidance learning in eating disorders and associations with symptoms. Aim 2: Evaluate whether corticostriatal and limbic-prefrontal fMRI BOLD response associated with avoidance learning differs in eating disorders relative to healthy controls and relates to symptoms. Aim 3: Evaluate whether functional connectivity of avoidance learning neural circuity differs in eating disorders relative to healthy controls.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2024
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2024
CompletedFirst Submitted
Initial submission to the registry
August 15, 2024
CompletedFirst Posted
Study publicly available on registry
August 22, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 31, 2027
May 1, 2026
April 1, 2026
2 years
August 15, 2024
April 27, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Learning rate
Behavioral responses during a card game gambling task
25 minutes
fMRI brain response
fMRI brain activity associated with the card game gambling task
25 minutes
Brain connectivity
Whole-brain functional connectivity associated with the card game gambling task
10 minutes
Study Arms (3)
Anorexia Nervosa
Participants that meet Diagnostic And Statistical Manual Of Mental Disorders (DSM-V) criteria for Anorexia Nervosa.
Bulimia Nervosa
Participants that meet DSM-V criteria for Bulimia Nervosa.
Healthy Controls
Participants that do not meet DSM-V criteria for any disorder.
Eligibility Criteria
The study will recruit 52 adult women currently ill with an eating disorder, including anorexia nervosa (AN; n=26) and bulimia nervosa (BN, n=26), and 26 healthy control (HC) women between the ages of 18 and 39.
You may qualify if:
- Eating Disorder Group:
- Between the ages of 18 and 39 years old
- Meet DSM-V criteria for anorexia nervosa or bulimia nervosa
- Healthy Controls:
- Between the ages of 18 and 39 years old
- Have maintained 85% to 120% ideal body weight since menarche
You may not qualify if:
- Psychotic illness/other mental illness requiring hospitalization
- Current dependence on drugs or alcohol defined by DSM IV criteria. Additionally, positive test results for drug use on the day of the scan, apart of marijuana, will result in cancelling or rescheduling the scan because acute use will impact MRI measures.
- Physical conditions (e.g. diabetes mellitus, pregnancy) known to influence eating or weight
- Neurological disorder, neurodevelopmental disorder, or history of head injury with \>30 min loss of consciousness
- Any contraindication to undergoing an MRI
- Primary obsessive compulsive disorder or primary major depressive disorder
- If taking other psychotropic medication, any change in dosage in the 2 weeks before scanning
- Meet criteria for the diagnosis of any psychiatric disorder currently
- Any history of binge eating or purging behaviors, including self-induced vomiting, laxative or diuretic misuse
- Use of any psychoactive or other medication known to affect mood or concentration in the last 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UCSD Eating Disorders Treatment and Research Program
La Jolla, California, 92121, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor in Residence
Study Record Dates
First Submitted
August 15, 2024
First Posted
August 22, 2024
Study Start
August 1, 2024
Primary Completion (Estimated)
July 31, 2026
Study Completion (Estimated)
July 31, 2027
Last Updated
May 1, 2026
Record last verified: 2026-04